SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-13-000845
Filing Date
2013-05-01
Accepted
2013-05-01 16:17:35
Documents
2
Period of Report
2013-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 vsta8kmay12013.htm 8-K 28242
2 ex10-1.htm EX-10.1 24187
  Complete submission text file 0001415889-13-000845.txt   53677
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54014 | Film No.: 13803412
SIC: 2834 Pharmaceutical Preparations